Latest:

Fat Pitch Financials

Special situation stocks and value investing

Stock Quote

Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Infinity Pharmaceuti (NQ: INFI)
1.410 USD  -0.040 (-2.76%)
Official Closing Price  /  Updated: 4:00 PM EST, Nov 16, 2018  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 843,500
Open 1.500
Bid (Size) 1.380 (12)
Ask (Size) 1.440 (13)
Prev. Close 1.450
Today's Range 1.360 - 1.500
52wk Range 1.260 - 2.920
Shares Outstanding 56,069,632
Dividend Yield N/A
Performance
YTD
-36.77%
-36.77%
1 Month
-47.19%
-47.19%
3 Month
-29.50%
-29.50%
6 Month
-29.15%
-29.15%
1 Year
-28.06%
-28.06%
Top News
More News
Infinity Reports Clinical and Translational Data from Expansion Cohorts of MARIO?1 Phase 1b Study of IPI-549 in Combination with Opdivo® (nivolumab) at SITC's 33rd Annual Meeting
-- Clinical Activity and Translational Data from IPI-549 in Monotherapy and in Combination with Opdivo Support On-Mechanism Proof of Concept -- Read More
from PR Newswire
Detailed Research: Economic Perspectives on MetLife, Callon Petroleum, Five9, Ballard Power, Infinity Pharmaceuticals, and Commercial Vehicle Group — What Drives Growth in Today's Competitive Landscap
In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of MetLife, Inc.... Read More
from GlobeNewswire News Releases
More News
Read More
Infinity Pharmaceuticals Provides Company Update and Third Quarter 2018 Financial Results
from PR Newswire
Bristol-Myers Squibb and Infinity Pharmaceuticals Announce a New Clinical Collaboration to Evaluate Opdivo (Nivolumab) in Combination with IPI-549 in Urothelial Cancer
from PR Newswire
Infinity Announces IPI-549 Late-Breaking Presentation at SITC 33rd Annual Meeting
from PR Newswire
Infinity Announces the Date of Its Third Quarter 2018 Financial Results Conference Call and Webcast
from PR Newswire
Bristol-Myers Squibb and Infinity Pharmaceuticals Announce a New Clinical Collaboration to Evaluate Opdivo (Nivolumab) in Combination with IPI-549 in Urothelial Cancer
from Business Wire News Releases
Mid-Afternoon Market Update: OPKO Health Rises On Q3 Earnings; Lumentum Shares Plummet
category APTI , Intraday Update , LITE , and 14 more.
from Benzinga
Mid-Day Market Update: Dow Down Over 400 Points; Apptio Shares Spike Higher
category Markets , FE , ATHN , and 14 more.
from Benzinga
Mid-Morning Market Update: Markets Open Lower; Veritas Capital To Buy Athenahealth For $5.7B
category Intraday Update , APTI , RSLS , and 15 more.
from Benzinga
UPDATE 1-Roche scores win in slowing aggressive type of breast cancer
category companyNews
from Reuters: Company News
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.